Page last updated: 2024-08-25

voriconazole and Left Ventricular Outflow Obstruction

voriconazole has been researched along with Left Ventricular Outflow Obstruction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cattaneo, L; Cereda, AF; Fiocca, L; Iacovoni, A; Senni, M; Sironi, S1
Basso, C; Biffanti, R; Milanesi, O; Stellin, G; Thiene, G; Vida, V1

Other Studies

2 other study(ies) available for voriconazole and Left Ventricular Outflow Obstruction

ArticleYear
An unusual case of cardiac aspergillosis.
    European heart journal, 2019, 03-21, Volume: 40, Issue:12

    Topics: Antifungal Agents; Aspergillosis; Echocardiography; Fatal Outcome; Female; Galactose; Heart; Humans; Mannans; Middle Aged; Tomography, X-Ray Computed; Ventricular Outflow Obstruction; Voriconazole

2019
Images in cardiovascular medicine. Left ventricular mass after treatment with chemotherapic drugs.
    Circulation, 2004, Jun-01, Volume: 109, Issue:21

    Topics: Acute Disease; Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Combined Modality Therapy; Echocardiography; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Leukemia, Myeloid; Male; Myelodysplastic Syndromes; Pyrimidines; Triazoles; Ventricular Outflow Obstruction; Voriconazole

2004